Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride

Reuters
Posted: 2008-11-07 16:19:32+05:30 IST
Updated: Nov 07, 2008 at 1619 hrs IST

Font Size

Feedback

Discuss

Taro asks Sun to pay $15 a share for merger Aurobindo gets Canada's nod for epilepsy drug Strides Acrolab gets USFDA nod for anti-infection ...Aurobindo Pharma gets US nod for Stavudine

Mumbai, November 7: : Aurobindo Pharma on Friday said it got final approval from the US Food and Drug Administration to make and market a 20 mg dose of Sertraline Hydrochloride.

Sertraline is the generic equivalent of Pfizer's Zoloft used for the treatment of depressive disorder in adults.

Discuss this story on expressindia forums

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.

Latest News

Print Edition

Events

Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride

Post Comments